A study has been undertaken on the relative merits of a variety of acute phase proteins in the assessment of patients with inflammatory conditions. Five acute phase proteins (c.-antitrypsin, aJ-antichymotrypsin, orosomucoid, haptoglobin and C-reactive protein) and the ESR were measured in 171 patients presenting to the gastroenterologists (gastrointestinal disease: 130, other disease: 41). Assessment of the sensitivity and specificity of the proteins and the ESR showed a,-antichymotrypsin to be the most sensitive test (95%) with specificity (81%) similar to the other acute phase proteins measured. Factors such as oestrogens, renal failure and genetic variants affected the value of ai-antitrypsin, orosomucoid and haptoglobin. In the routine protein laboratory the combination of a 'short' half-life and 'long' half-life protein is likely to offer the most useful screen for inflammation in samples obtained from a wide range of patients. The two acute phase proteins C-reactive protein and al-antichymotrypsin fulfil these criteria.
SUMMARY.
A study has been undertaken on the relative merits of a variety of acute phase proteins in the assessment of patients with inflammatory conditions. Five acute phase proteins (c.-antitrypsin, aJ-antichymotrypsin, orosomucoid, haptoglobin and C-reactive protein) and the ESR were measured in 171 patients presenting to the gastroenterologists (gastrointestinal disease: 130, other disease: 41). Assessment of the sensitivity and specificity of the proteins and the ESR showed a,-antichymotrypsin to be the most sensitive test (95%) with specificity (81%) similar to the other acute phase proteins measured. Factors such as oestrogens, renal failure and genetic variants affected the value of ai-antitrypsin, orosomucoid and haptoglobin. In the routine protein laboratory the combination of a 'short' half-life and 'long' half-life protein is likely to offer the most useful screen for inflammation in samples obtained from a wide range of patients. The two acute phase proteins C-reactive protein and al-antichymotrypsin fulfil these criteria.
'Acute phase proteins' are a group of proteins whose concentration in the serum increases following tissue injury. Many acute phase proteins have been identified,' the most commonly measured proteins being at-antitrypsin, orosomucoid, haptoglobin and C-reactive protein. The extent of the increase in serum level and the half-life of the protein in the circulation differs for each of the acute phase proteins and thus the pattern of change with time for a given stimulus depends on the protein.? Factors other than inflammation and tissue injury may also influence the levels of the proteins to different degrees; for example oestrogens," steroid therapy," haemolysis.? renal function" and the existence of phenotypic variants.P' 7 The literature on acute phase proteins indicates that serum al-antichymotrypsin is one of the most specific indicators of the acute phase reaction with levels not being influenced by other factors."
Some of the early experience with the clinical value of the acute phase protein measurements was based on the use of a profile of tests. The patterns of results which may be obtained in various disease states (e.g. haemolysis, liver disease) have been described by Laurell." The use of a profile of tests was more practicable 60 when using some of the manual techniques. However, the measurement of a battery of protein tests on every patient regardless of the clinical problem may provide little additional information. The availability of automated rapid immunoturbidimetric techniques using high quality antiserum makes possible the more appropriate use of individual proteins in particular clinical situations.
This study was undertaken to compare the relative merits of a variety of acute phase proteins in the assessment of patients with inflammatory conditions.
Materials and methods

METHODS
Five acute phase proteins were measured.'ujantitrypsin, al-antichymotrypsin, orosomucoid, haptoglobin and C-reactive protein. C-reactive protein was measured using a latex-enhanced immunoturbidimetric assay (Extend CRP assay, Du Pont de Nemours, Wilmington, USA). 10 Haptoglobin, orosomucoid, a.-antitrypsin and al-antichymotrypsin were measured using immunoturbidimetric assays on an Instrumentation Laboratory Multistat centrifugal ana-lyser.!': 12 The reactions were monitored at 30"C and 340 nm for 3 min (at-antitrypsin, haptoglobin) or 6 min (al-antichymotrypsin, orosomucoid). Antisera were diluted in phosphate buffer (0·1 M, pH 7,4) containing polyethylene glycol 6000 (BOH, Poole, Dorset, UK). Samples were diluted I in 50 in saline with the exception of al-antichymotrypsin. Samples for this assay were diluted I in 10 in phosphate buffer containing polyethylene glycol 6000 (64 giL) and centrifuged before use. Antisera were obtained from Atlantic Antibodies (haptoglobin and ai-antitrypsin) and Dako (atantichymotrypsin and orosomucoid).
The ESR was measured using the Westergren technique. 13 
REFERENCE RANGES
Reference ranges were obtained using samples collected from blood donors.
The reference range for a.-antichymotrypsin was 0·33-0·64 giL (135 samples; 55 from women, 80 from men, age range 18-62 years). Referencerangesfora,-antitrypsin(l·o-l·8g1L), orosomucoid (0·5-1·0 gil) and haptoglobin (0·5-2·6 giL) were obtained by assaying 98 specimens (46 from women; 52 from men, age range 18-65 years).
The reference range for C-reactive protein was found to be less than 6 mglL (480 samples, 255 from men, 225 from women, age range 18-63 years).
Based on clinical experience the ESR was considered to be significantly elevated at 20 mmlh. PATIENTS (1) The time courses of the individual proteins were monitored by measuring the complete battery of proteins on a series of specimens from 22 patients undergoing coronary bypass surgery. Samples were collected immediately prior to the operation, then at 2 h, 6 h, 12h, 1, 3 and 7 days post-op. :::;
..... The medical records of the first 113 of these patients seen during a lo-week period in mid 1985 were reviewed retrospectively. The presence or absence of an inflammatory condition was made on the basis of the final diagnosis and of the clinical findings and radiology at the time of acute phase protein measurement (Table 1) . The sensitivity and specificityof the acute phase proteins (al-antichymotrypsin, aI-antitrypsin, C-reactive protein, orosomucoid and haptoglobin) and also of the ESR in detecting or excluding inflammation as defined by the c1incal assessment were calculated.
Results
The patterns of C-reactive protein and a\- antichymotrypsin levels in patients following coronary bypass surgery are shown in Figs la and b. The time courses for the other proteins measured are not shown, but were consistent with the literature. 14 The results for the patients presenting to the gastroenterologists are shown in Figs 2-6. The levels of each of the acute phase proteins (C-reactive protein, orosomucoid, a.-antitrypsin and haptoglobin) and the ESR are compared to al-antichymotrypsin. The data from patients with renal failure for orosomucoid and al-antichymotrypsin are also shown in Fig. 3 .
The sensitivity, specificity and predictive values for each of the variables measured are shown in Table 2 . 
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Discussion
There are numerous reports in the literature on the value of serum specific protein levels in the assessment of different diseases. However, in many instances, the concentrations have been interpreted with complete disregard for the time course of the acute phase reaction. The patterns and, therefore, the most appropriate protein(s) to measure, may change depending on the time of collection of the specimen. The time course for al-antichymotrypsin has not been as widely reported as that for the other acute phase proteins. Figure 1 shows the short time course of C-reactive protein in comparison with al-antichymotrypsin. Like C-reactive protein a.-antichymotrypsin is an early acute phase reactant but remains elevated for a considerably longer period. The results in the coronary bypass patients confirm that the late time course of al-antichymotrypsin is similar to that of orosomucoid, haptoglobin and al-antitrypsin. 2 In the comparison of al-antichymotrypsin and C-reactive protein (Fig. 2) 24 patients showed raised al-antichymotrypsin levels with normal C-reactive protein levels. A possible explanation is the short half-life of C-reactive protein. However, CRP is known to show poor responses in certain conditions (e.g. viral infections, 15 . 16 ulcerative colitis.!" 18 It has been suggested that C-reactive protein is not increased or shows only a modest rise in viral infection unless tissue damage occurs.l" This poor response in certain conditions may not be specific to C-reactive protein and other acute phase proteins including a.-antichymotrypsin may also show a muted response. Studies on diseases such as systemic sclerosis and systemic lupus erythematosus, where poor C-reactive protein responses are seen, suggest that there may be a fault in the production of interleukin 1. 2(1, 21 This may result in a depression ofthe entire acute phase response. However, the evidence for defective production of all acute phase proteins in certain diseases is inconclusive. Whicher et al. 22 have shown that the acute phase response following prostaglandin infusion is much diminished in patients with systemic sclerosis. The defective production was most apparent for serum amyloid A, C-reactive protein and (Xr-antichymotrypsin with no significant difference for haptoglobin, orosomucoid, (X)-antitwsin and caeruloplasmin. Weeke and Jarnum have reported similar changes in orosomucoid, (X)-antitrypsin, (X.-antichymotrypsin and haptoglobin in patients with Crohn's disease and those with ulcerative colitis. In a study on graft versus host disease following bone marrow transplant C-reactive protein was found to be a relatively insensitive marker compared with serum amyloid A and (X)-antichymotrypsin. 24 Further studies on (X.antichymotrypsin in viral infections and in ulcerative colitis are being undertaken. In this study one patient demonstrated an unexpected pattern of acute phase proteins with the C-reactive protein elevated whilst the (X.-antichymotrypsin and other proteins were normal; the patient died of liver failure shortly after admission and the observation remains unexplained. In the group of 171 patients presenting to the wards and clinics measurement of Creactive protein alone would have missed 16% of the acute phase responses as judged by changes in at least two of the other acute phase reactants. In 7% of the 171 patients the Creactive protein was normal with increases in all other proteins measured. The relatively long half-life of (X)-antichymotrypsin in comparison with C-reactive protein is potentially an advantage in the assessment of new patients. It is important that evidence of an acute phase reaction is not missed, particularly in patients being investigated for unexplained abdominal symptoms.
In the patients presenting to the gastroenterology clinics orosomucoid and (XI-antichymotrypsin ( Fig. 3) showed similar responses. A small number of patients had minor elevations in orosomucoid with normal (X.-antichymotrypsin levels. Clinically there was little explanation for the mildl~raised orosomucoid results. Lyngbye et al. 5 have reported slight increases in orosomucoid with age. In this study the mildly raised orosomucoid results were not age or sex-related. In the patients with chronic renal failure orosomucoid showed a more pronounced increase than (X,-antichymotrypsin. The effect of reduced glomerular filtration rate on circulating orosomucoid levels has been noted by other workers.?: 26 In the comparison of (XI-antichymotrypsin and (X)-antitrypsin ( Fig. 4 ) several specimens showed raised ul-antichymotrypsin levels in the absence of increased (X.-antitrypsin; some of these results may be accounted for by differences in the time courses for the two proteins, (X.-antichymotrypsin increasing more rapidly than (X.-antitrypsin. However, (XI-antitrypsin is often a poor indicator of inflammation, especially in processes involving mesenchymal tissue (e.g. in rheumatoid arthritis)." It is wellknown that oestrogens cause an elevation of (X1-antitrypsin 3 and four of the most discrepant results showing elevations in (XI-antitrypsin and not (X.-antichymotrypsin proved to be from patients taking the oral contraceptive pill. In a separate study on patients with rheumatoid arthritis the presence of MZ and MS phenotypes markedly reduced the value of (XI-antitrypsin as a marker of inflammation (unpublished observations).
In the comparison of (X.-antichymotrypsin with haptoglobin ( Fig. 5 ) there were a large number of specimens with raised (XI-antichymotrypsin yet normal haptoglobin levels. The sensitivity of haptoglobin as a marker of inflammation was generally poor due to the wide normal range for this protein; this reflects the different phenotypes." There was no evidence of haemolysis in these patients to explain reduced levels of haptoglobin.
There were several specimens showing discrepant results in the comparison of (XI-antichymotrypsin and the ESR (Fig. 6 ). The ESR is most affected by the fibrinogen concentrations, but reflects changes in several proteins. Fibrinogen is an acute phase protein, but is slow to change in concentration and may be catabolised in some disease processes. I Assessment of the sensitivity and specificity of each of the proteins showed (XI-antichymotrypsin to be by far the most sensitive test (95% sensitivity) with specificity (81%) similar to the other acute phase proteins; overall u.-antichymotrypsin demonstrated a superior predictive value compared with the other tests. The positive predictive values of the individual proteins ranged from 58-75%. The relatively poor predictive value of these tests may reflect the difficulty of clinically assessing very mild degrees of inflammation.
A retrospective assessment of patients is not ideal so a prospective study to evaluate UIantichymotrypsin as a marker of inflammation is planned.
In the assessment of inflammation there seems to be little gained from measuring a battery of tests. This study has supported the contention that the sensitivity of some of the candidate markers of the acute phase reaction is limited due to the existence of variant forms. The two most important characteristics for a successful marker of the acute phase reaction are the specificity of the test (i.e. levels not affected by other factors) and the period of elevation.
It has been argued that C-reactive protein is the ideal marker of the acute phase reaction when monitoring inflammatory disease activity.' This may be the case in an acute condition but may not be the case with a chronic disease when samples are taken less . frequently. Bull et al. 27 in a recent study of patients with rheumatoid arthritis collecting samples at monthly intervals found C-reactive protein to be less sensitive than orosomucoid. The work reported here would suggest that UIantichymotrypsin is the most useful acute phase protein in detecting inflammation in gastroenterology/general medicine patients, particularly in the out-patient clinic. The data on the patterns of change in this report indicate that a sample taken eight days after an event stimulating an acute phase response is likely to yield a normal C-reactive protein level. However, we would propose that the combination of a 'short' and a 'long' half-life protein is likely to offer the most useful screen for inflammation in the routine protein laboratory analysing specimens from a wide range of patients. The two acute phase proteins Creactive protein and ul-antichymotrypsin f1fil these criteria.
